Liquid Biopsies: A Fundamental Advance in Cancer Care-Mark Jacobstein-05/09/2017 - 6:00pm

Event Information
Event Topic: 
Liquid Biopsies: A Fundamental Advance in Cancer Care
Event Date: 
05/09/2017 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati - 650 Page Mill Road, Palo Alto
Speaker Information
Event Speaker: 
Mark Jacobstein
Event Speaker Title: 
Chief User Engagement Officer
Event Speaker Company: 
Guardant Health
Event Speaker Bio: 

Mark is the Chief User Engagement Officer for Guardant Health, the world’s leaders in liquid biopsies. Mark was the CEO of iSkoot before selling the company to Qualcomm, where he led Qualcomm iSkoot Technologies. Prior Mark was an EVP at loopt, and the founding President of Digital Chocolate. Mark was the CEO and founder of Small World Sports, the world's first online fantasy sports business, which he sold to Paul Allen's The Sporting News. In 1994 Mark co-founded Small World Software, an Internet technology consultancy, which he sold to iXL in 1998.

Event Details
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
Event Details: 

Liquid Biopsies use circulating biomarker signals (e.g. circulating tumor DNA) found in blood to characterize, and potentially even detect, cancer tumors. Their growth in clinical use for advanced cancer therapy selection is just the start; potential uses include residual disease and early disease detection, and their insights into tumor-genesis and tumor-evolution may be a key for cancer research. Mark Jacobstein, the Chief User Engagement Officer at Guardant Health, the world’s leaders in liquid biopsies, will give an overview of this new technology and its current and potential future utility.